secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2025-07-08T23:59:59+00:00
Accession:  0001104659-25-066418
Event type: regulatory
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Entero Therapeutics regains Nasdaq annual meeting compliance
------------------------------------------------------------

- Received Nasdaq letter confirming compliance with Listing Rule 5620(a) after holding Annual Meeting on June 30, 2025.
- Matter is now closed; no further action required from Nasdaq.
- Company had previously reported the meeting in a Form 8-K filed July 2, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925066418/0001104659-25-066418-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925066418/tm2520095d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-066418

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer